As of January 2025, Wuhan Easy Diagnosis Biomedicine has a market cap of $597.56M. This makes Wuhan Easy Diagnosis Biomedicine the world's 10316th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $593.09M | -18.98% |
2023 | $732.05M | -59.89% |
2022 | $1.83B | -22.61% |
2021 | $2.36B | 64.34% |
2020 | $1.44B | 74.10% |
2019 | $824.29M | -17.93% |
2018 | $1.00B | - |